11.01.06
Phoenix Biologics to Manufacture Migraine Prevention Product
Phoenix Biologics Inc., (PBI) Vista, CA, has announced an agreement with Migco Pharmaceuticals Ltd., Christchurch, New Zealand, to manufacture and distribute a new natural health product for migraine prevention. The new dietary supplement will strengthen the PBI product line and its mission to provide natural choices for health and well being. Migco Pharmaceuticals Ltd. will be supporting the product with scientific data and studies.
Earlier this year, Migco Pharmaceuticals was granted a patent based on the findings from a study conducted by Dr. Chayasirisobhon of Kaiser Permanente. The study links the use of Monterey pine (Pinus radiata extract) to a reduction in incidence and intensity of migraine headaches. Phoenix Biologics has the licensing agreement to manufacture the product Liberate, which will contain the branded ingredient Preoxus (Monterey pine—Pinus radiata extract) from Migco Pharmaceuticals.
Phoenix Biologics Inc., (PBI) Vista, CA, has announced an agreement with Migco Pharmaceuticals Ltd., Christchurch, New Zealand, to manufacture and distribute a new natural health product for migraine prevention. The new dietary supplement will strengthen the PBI product line and its mission to provide natural choices for health and well being. Migco Pharmaceuticals Ltd. will be supporting the product with scientific data and studies.
Earlier this year, Migco Pharmaceuticals was granted a patent based on the findings from a study conducted by Dr. Chayasirisobhon of Kaiser Permanente. The study links the use of Monterey pine (Pinus radiata extract) to a reduction in incidence and intensity of migraine headaches. Phoenix Biologics has the licensing agreement to manufacture the product Liberate, which will contain the branded ingredient Preoxus (Monterey pine—Pinus radiata extract) from Migco Pharmaceuticals.